Lv2
140 积分 2025-11-07 加入
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
3个月前
已关闭
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance
3个月前
已完结
Targeting Innate Immune Checkpoint TREX1 is a Safe and Effective Immunotherapeutic Strategy in Cancer
4个月前
已完结
皖公网安备34019202002308
